Bone health care in breast cancer survivors
Breast cancer is the most common type of cancer affecting women, while the majority are treated for cure nowadays. Therefore, monitoring of long-term consequences is necessary and important, with bone heath representing a very essential parameter. Anti-hormonal therapies are often used to reduce the risk of breast cancer recurrence. Aromatase inhibitors (AIs) reduce the peripheral conversion of androgens to estrogens. Both the steroidal (exemestane) and non-steroidal AIs (letrozole and anastrazole) have been associated with bone loss and increased risk of fractures.
Source: Maturitas - Category: Primary Care Authors: Stavroula A. Paschou Tags: INV13 Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Health Management | Hormones | Orthopaedics | Primary Care | Women